Literature DB >> 29886280

Review fantastic medical implications of 3D-printing in liver surgeries, liver regeneration, liver transplantation and drug hepatotoxicity testing: A review.

Jing-Zhang Wang1, Nan-Yan Xiong2, Li-Zhen Zhao3, Jin-Tian Hu3, De-Cheng Kong2, Jiang-Yong Yuan4.   

Abstract

The epidemiological trend in liver diseases becomes more serious worldwide. Several recent articles published by International Journal of Surgery in 2018 particularly emphasized the encouraging clinical benefits of hepatectomy, liver regeneration and liver transplantation, however, there are still many technical bottlenecks underlying these therapeutic approaches. Remarkably, a few preliminary studies have shown some clues to the role of three-dimensional (3D) printing in improving traditional therapy for liver diseases. Here, we concisely elucidated the curative applications of 3D-printing (no cells) and 3D Bio-printing (with hepatic cells), such as 3D-printed patient-specific liver models and devices for medical education, surgical simulation, hepatectomy and liver transplantation, 3D Bio-printed hepatic constructs for liver regeneration and artificial liver, 3D-printed liver tissues for evaluating drug's hepatotoxicity, and so on. Briefly, 3D-printed liver models and bioactive tissues may facilitate a lot of key steps to cure liver disorders, predictably bringing promising clinical benefits. This work further provides novel insights into facilitating treatment of hepatic carcinoma, promoting liver regeneration both in vivo and in vitro, expanding transplantable liver resources, maximizing therapeutic efficacy as well as minimizing surgical complications, medical hepatotoxicity, operational time, economic costs, etc.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  3D printing; Hepatotoxicity; Liver constructs; Liver regeneration; Liver transplantation; Surgical simulation

Mesh:

Year:  2018        PMID: 29886280     DOI: 10.1016/j.ijsu.2018.06.004

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

Review 1.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

Review 2.  Discussing the final size and shape of the reconstructed tissues in tissue engineering.

Authors:  Javad Esmaeili; Aboulfazl Barati; Letícia Emiliano Charelli
Journal:  J Artif Organs       Date:  2022-09-20       Impact factor: 1.385

3.  PIN1, a perspective on genetic biomarker for nonalcoholic fatty liver disease (NAFLD).

Authors:  Jing-Zhang Wang; Yu-Hua Zhang; Jing Bai; Yan-Wei Liu; Wen-Tao Du
Journal:  Metabol Open       Date:  2019-08-06

Review 4.  Role of innovative 3D printing models in the management of hepatobiliary malignancies.

Authors:  Peter Bangeas; Vassilios Tsioukas; Vasileios N Papadopoulos; Georgios Tsoulfas
Journal:  World J Hepatol       Date:  2019-07-27

Review 5.  Three-dimensional printing for cardiovascular diseases: from anatomical modeling to dynamic functionality.

Authors:  Hao Wang; Hongning Song; Yuanting Yang; Quan Cao; Yugang Hu; Jinling Chen; Juan Guo; Yijia Wang; Dan Jia; Sheng Cao; Qing Zhou
Journal:  Biomed Eng Online       Date:  2020-10-07       Impact factor: 2.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.